» Articles » PMID: 31126056

Circulating MiRNAs As Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer-An Overview

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 May 26
PMID 31126056
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: We selected the reviewed papers from Google Academic, PubMed, and CrossRef. A total of eight studies met the inclusion criteria.

Results: MiR-200 family, miR-143, 145, miR-20a, and miR199a were the most commonly dysregulated miRNAs in endometriosis, and miR-200 family was found to be dysregulated in both ERONs and endometriosis.

Conclusions: No single miRNA was considered as a sole biomarker for this pathology. However, since the prognostic value of biomarkers is generally enhanced if more are assessed at the same time, a panel of miRNAs could be a better indicator of the disease.

Citing Articles

Advances in research on malignant transformation of endometriosis-associated ovarian cancer.

Chen F, Zhu M, Li W Front Oncol. 2024; 14:1475231.

PMID: 39445058 PMC: 11496038. DOI: 10.3389/fonc.2024.1475231.


Diagnostic Value and Molecular Function of MicroRNAs in Endometrial Diseases: A Systematic Review.

Kluz N, Kowalczyk E, Wasilewska M, Gil-Kulik P Cancers (Basel). 2024; 16(13).

PMID: 39001478 PMC: 11240806. DOI: 10.3390/cancers16132416.


Immune pathway through endometriosis to ovarian cancer.

Santos Calmon M, Bueno Lemos F, Silva Luz M, Rocha Pinheiro S, de Oliveira Silva L, Lima Correa Santos G World J Clin Oncol. 2024; 15(4):496-522.

PMID: 38689629 PMC: 11056862. DOI: 10.5306/wjco.v15.i4.496.


Endometriosis-Related Ovarian Cancer: Where Are We Now? A Narrative Review towards a Pragmatic Approach.

Centini G, Schettini G, Pieri E, Giorgi M, Lazzeri L, Martire F J Clin Med. 2024; 13(7).

PMID: 38610698 PMC: 11012952. DOI: 10.3390/jcm13071933.


miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer.

Szubert M, Nowak-Gluck A, Domanska-Senderowska D, Szymanska B, Sowa P, Rycerz A Int J Mol Sci. 2023; 24(24).

PMID: 38139300 PMC: 10743418. DOI: 10.3390/ijms242417470.


References
1.
Lapp T . ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists. Am Fam Physician. 2000; 62(6):1431, 1434. View

2.
Thomas E, Campbell I . Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest. 2000; 50 Suppl 1:2-10. DOI: 10.1159/000052872. View

3.
Cramer D, Missmer S . The epidemiology of endometriosis. Ann N Y Acad Sci. 2002; 955:11-22; discussion 34-6, 396-406. DOI: 10.1111/j.1749-6632.2002.tb02761.x. View

4.
Swiersz L . Role of endometriosis in cancer and tumor development. Ann N Y Acad Sci. 2002; 955:281-92; discussion 293-5, 396-406. DOI: 10.1111/j.1749-6632.2002.tb02788.x. View

5.
Lee Y, Jeon K, Lee J, Kim S, Kim V . MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002; 21(17):4663-70. PMC: 126204. DOI: 10.1093/emboj/cdf476. View